Yongpeng Ji

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in the Localized Prostate Cancer and Benign Prostate Hyperplasia: A Retrospective Clinical Study

Shuo Wang, Yongpeng Ji, Yanyun Chen et al. · Frontiers in Oncology · 2022 · 34 citations · Full text

Medicine, Pathology, Urology +17

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population

Qiang Zhao, Xue Jia, Baoan Hong et al. · Cancer Cell International · 2020 · 32 citations · Full text

Medicine, Genetics, Oncology +17

Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial.

Xinan Sheng, Cuijian Zhang, Yongpeng Ji et al. · Journal of Clinical Oncology · 2025 · 17 citations

Medicine, Oncology, Pharmacology +17

The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study

Shuo Wang, Xiao Yang, Ziyi Yu et al. · Frontiers in Oncology · 2022 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Preliminary efficacy and safety results from RC48-C017: A phase II study of neoadjuvant treatment with disitamab vedotin plus toripalimab in patients with muscle invasive bladder cancer (MIBC) with HER2 expression.

Xinan Sheng, Kaiwei Yang, Yongpeng Ji et al. · Journal of Clinical Oncology · 2024 · 12 citations

Medicine, Oncology, Pharmacology +17